The civic record
Read. Follow. Verify.Lobbying Report: Association for Career and Technical Education (Q2 2026)
Record date · July 20, 2026
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
What This Bill Does
This report details the lobbying activities and $20,000 in expenses for the Association for Career and Technical Education (ACTE) during the second quarter of 2026. The organization focused on advocating for career and technical education funding, specific education-related legislation, and workforce development policies.
This document discloses the specific legislative priorities and financial spending of a professional association attempting to influence federal education and workforce policy for the 2027 .
Who It Affects
Groups the bill's text affects, as described in the record. Being affected is not a position for or against it.
ACTE
The organization is actively lobbying federal agencies to influence legislation and budget appropriations.
Career and Technical Education (CTE) programs
These programs are the subject of proposed funding increases and legislative reauthorization efforts mentioned in the report.
Key Facts
You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.
Frequently Asked Questions
How much did ACTE spend on lobbying this quarter?
What is the primary goal of ACTE's lobbying efforts?
What else do you want to know?
News Coverage
Follow the record
Votes, people, money & the original sourceLobbying Activity
A16Z Capital Management LLC (f/k/a AH Capital Management L.L.C., d/b/a Andreessen Horowitz)
on behalf of A16Z Capital Management LLC (f/k/a AH Capital Management L.L.C.)
2026
“Digital assets and anti-money laundering proposals”
The Cleveland Clinic Foundation
on behalf of Cleveland Clinic Foundation
2026
“Quantum computing Immigration Issues National Institute of Health CHILDReN Act EARLY Minds Act Interoperability Issues Brain Health 340B Graduate Medical Education Workforce Issues Payer Accountability Organ Transplant Legislation Healthy Competition Act Price Transparency ”
ACG Advocacy
on behalf of 11:11 Media Impact
2026
“Youth treatment facility oversight. Foster care issues.”
ACG Advocacy
on behalf of 7 Eleven, Inc.
2026
“Monitor Labor Issues. ”
1-800 Contacts, Inc.
2026
“Issues and legislative proposals related to contact lenses Issues related to the Federal Trade Commission Contact Lens Rule H.R.8773: Financial Services and General Government Appropriations Act, 2025 H.R. 9027: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2025 HR 4282 S. 3354, Curtis QUIET Act.”
A.O. Smith Corporation
2026
“H.R. 1 One Big Beautiful Bill Act”
A STREET STRATEGIES
on behalf of National Association of Convenience Stores
2026
“Issues relating to renewable fuels and energy policy Issues relating to UST regulations Issues relating to renewable fuels standard implementation Issues relating to retailer liability associated with selling alternative and renewable fuels Issues relating to the gasoline and diesel fuel excise tax Issues relating to Biodiesel Blenders' Tax Credit Issues relating to the Alternative Fuel Vehicle Refueling Property tax credit Issues relating to Gas prices and fuel markets, price gouging E15 RVP waiver”
ADOBE INC
2026
“IT Modernization and Digital Service delivery issues; Digital Service Delivery IT Acquisition, and Content Authenticity and digital provenance issues; Content Authenticity Initiative (CAI); artificial intelligence; content provenance; privacy; technology in and competition issues; AI innovation and the economy; Content provenance and AI Labelling; IT modernization; Support for H.R. 9112 - CREATOR Act”
ACADIA PHARMACEUTICALS
2026
“Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Mikaela Naylon Give Kids A Chance Act (HR 1262), Give Kids A Chance Act (S 932), Cameron's Law (HR 1414), Kids Access to Care Act (Accelerating HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), BINSA Act, H.R. 9102, Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.”
340B Health
2026
“The SECURE 340B Act (H.R. 9599); The Tax-Exempt Hospital Transparency Act (H.R.9504); 340B PATIENTS Act (H.R. 4581/S.2372); Community Health Center Drug Pricing Protection Act (H.R. 7391); 2027 OPPS Proposed Rule; Information Collection Request Title: 340B Rebate Model Pilot Program Application, Implementation, and Evaluation, OMB Number 0906-NEW; Manufacturer Demand for Access to in-House Pharmacy Claims Data; Lilly 340B Drug Pricing Denial; HRSA Rebate Model Pilot pending regulation; Pending Senate "Gang of Six" draft 340B legislation; FY27 Appropriations legislation; Pending introduction of updated and expanded Community Health Center Drug Pricing Protection Act.”
Full breakdown
Who this bill affects and the strongest case for and against it, written only from the bill’s own text.
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Connected Entities
Sources
lda.gov
Analysis Score
0–100- Significance40How much this matters to a regular citizen
- Controversy10Intensity of disagreement among stakeholders
- Entertainment5Compellingness for a non-policy-wonk reader
- Buzz10Current news / social attention level
Publisher tools